The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Acute Coronary Syndrome (ACS)-Global Market Insights and Sales Trends 2024

Acute Coronary Syndrome (ACS)-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1858932

No of Pages : 89

Synopsis
Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, crushing, central and associated with nausea and sweating. Many people with acute coronary syndromes present with symptoms other than chest pain, particularly, women, older patients, and patients with diabetes mellitus.
The global Acute Coronary Syndrome (ACS) market size is expected to reach US$ 10110 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Acute Coronary Syndrome (ACS) in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Center and Diagnostic Centers,, are propelling Acute Coronary Syndrome (ACS) market. Monotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Combination Therapy segment is estimated at % CAGR for the next seven-year period.
Increase in geriatric population and rise in the incidence of cardiac disorders are the major factors that drive the market growth. However, stringent government regulations for the approval of drugs are expected to restrain the market growth. Improvement in healthcare facilities in emerging regions such as Asia-Pacific and LAMEA are expected to provide new growth opportunities for the market during the analysis period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Acute Coronary Syndrome (ACS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Acute Coronary Syndrome (ACS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Acute Coronary Syndrome (ACS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Acute Coronary Syndrome (ACS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Acute Coronary Syndrome (ACS) covered in this report include Dexa Medica, GlaxoSmithKline, Novartis, Pfizer, Sanofi, Serum Institute of India, Biogen and Eli Lilly and Company, etc.
The global Acute Coronary Syndrome (ACS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Dexa Medica
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Serum Institute of India
Biogen
Eli Lilly and Company
Global Acute Coronary Syndrome (ACS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Acute Coronary Syndrome (ACS) market, Segment by Type:
Monotherapy
Combination Therapy
Global Acute Coronary Syndrome (ACS) market, by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Acute Coronary Syndrome (ACS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Acute Coronary Syndrome (ACS)
1.1 Acute Coronary Syndrome (ACS) Market Overview
1.1.1 Acute Coronary Syndrome (ACS) Product Scope
1.1.2 Acute Coronary Syndrome (ACS) Market Status and Outlook
1.2 Global Acute Coronary Syndrome (ACS) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Acute Coronary Syndrome (ACS) Market Size by Region (2018-2029)
1.4 Global Acute Coronary Syndrome (ACS) Historic Market Size by Region (2018-2023)
1.5 Global Acute Coronary Syndrome (ACS) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Acute Coronary Syndrome (ACS) Market Size (2018-2029)
1.6.1 North America Acute Coronary Syndrome (ACS) Market Size (2018-2029)
1.6.2 Europe Acute Coronary Syndrome (ACS) Market Size (2018-2029)
1.6.3 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size (2018-2029)
1.6.4 Latin America Acute Coronary Syndrome (ACS) Market Size (2018-2029)
1.6.5 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size (2018-2029)
2 Acute Coronary Syndrome (ACS) Market by Type
2.1 Introduction
2.1.1 Monotherapy
2.1.2 Combination Therapy
2.2 Global Acute Coronary Syndrome (ACS) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Acute Coronary Syndrome (ACS) Historic Market Size by Type (2018-2023)
2.2.2 Global Acute Coronary Syndrome (ACS) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Acute Coronary Syndrome (ACS) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Acute Coronary Syndrome (ACS) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Acute Coronary Syndrome (ACS) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Acute Coronary Syndrome (ACS) Revenue Breakdown by Type (2018-2029)
3 Acute Coronary Syndrome (ACS) Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Center
3.1.3 Diagnostic Centers
3.2 Global Acute Coronary Syndrome (ACS) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Acute Coronary Syndrome (ACS) Historic Market Size by Application (2018-2023)
3.2.2 Global Acute Coronary Syndrome (ACS) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Acute Coronary Syndrome (ACS) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Acute Coronary Syndrome (ACS) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Acute Coronary Syndrome (ACS) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Acute Coronary Syndrome (ACS) Revenue Breakdown by Application (2018-2029)
4 Acute Coronary Syndrome (ACS) Competition Analysis by Players
4.1 Global Acute Coronary Syndrome (ACS) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Coronary Syndrome (ACS) as of 2022)
4.3 Date of Key Players Enter into Acute Coronary Syndrome (ACS) Market
4.4 Global Top Players Acute Coronary Syndrome (ACS) Headquarters and Area Served
4.5 Key Players Acute Coronary Syndrome (ACS) Product Solution and Service
4.6 Competitive Status
4.6.1 Acute Coronary Syndrome (ACS) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Dexa Medica
5.1.1 Dexa Medica Profile
5.1.2 Dexa Medica Main Business
5.1.3 Dexa Medica Acute Coronary Syndrome (ACS) Products, Services and Solutions
5.1.4 Dexa Medica Acute Coronary Syndrome (ACS) Revenue (US$ Million) & (2018-2023)
5.1.5 Dexa Medica Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Acute Coronary Syndrome (ACS) Products, Services and Solutions
5.2.4 GlaxoSmithKline Acute Coronary Syndrome (ACS) Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Acute Coronary Syndrome (ACS) Products, Services and Solutions
5.3.4 Novartis Acute Coronary Syndrome (ACS) Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Acute Coronary Syndrome (ACS) Products, Services and Solutions
5.4.4 Pfizer Acute Coronary Syndrome (ACS) Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Acute Coronary Syndrome (ACS) Products, Services and Solutions
5.5.4 Sanofi Acute Coronary Syndrome (ACS) Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Serum Institute of India
5.6.1 Serum Institute of India Profile
5.6.2 Serum Institute of India Main Business
5.6.3 Serum Institute of India Acute Coronary Syndrome (ACS) Products, Services and Solutions
5.6.4 Serum Institute of India Acute Coronary Syndrome (ACS) Revenue (US$ Million) & (2018-2023)
5.6.5 Serum Institute of India Recent Developments
5.7 Biogen
5.7.1 Biogen Profile
5.7.2 Biogen Main Business
5.7.3 Biogen Acute Coronary Syndrome (ACS) Products, Services and Solutions
5.7.4 Biogen Acute Coronary Syndrome (ACS) Revenue (US$ Million) & (2018-2023)
5.7.5 Biogen Recent Developments
5.8 Eli Lilly and Company
5.8.1 Eli Lilly and Company Profile
5.8.2 Eli Lilly and Company Main Business
5.8.3 Eli Lilly and Company Acute Coronary Syndrome (ACS) Products, Services and Solutions
5.8.4 Eli Lilly and Company Acute Coronary Syndrome (ACS) Revenue (US$ Million) & (2018-2023)
5.8.5 Eli Lilly and Company Recent Developments
6 North America
6.1 North America Acute Coronary Syndrome (ACS) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Acute Coronary Syndrome (ACS) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acute Coronary Syndrome (ACS) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acute Coronary Syndrome (ACS) Market Dynamics
11.1 Acute Coronary Syndrome (ACS) Industry Trends
11.2 Acute Coronary Syndrome (ACS) Market Drivers
11.3 Acute Coronary Syndrome (ACS) Market Challenges
11.4 Acute Coronary Syndrome (ACS) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’